British-Swedish pharmaceutical company AstraZeneca said Friday that it will start to book a modest profit from its coronavirus vaccine as it moves away from the nonprofit model it has operated during the pandemic.
from Section Page News - Modern Healthcare https://ift.tt/3CgKt5e
